Anti-inflammatory effects of alpha-tocopherol

Area of Science:

• Cardiovascular Science
• Inflammation Research
• Nutritional Science

Background:

• Cardiovascular disease (CVD) is a leading cause of death globally, with increasing incidence in developing nations.
• Inflammation, involving cytokines, chemokines, and immune cells, plays a critical role in atherosclerosis development.
• C-reactive protein (CRP) is an inflammation marker and a risk factor for CVD, potentially contributing to atherosclerosis.

Purpose of the Study:

• To review the anti-inflammatory effects of alpha-tocopherol in in vivo studies.
• To explore alpha-tocopherol's potential role in preventing and treating cardiovascular disease.

Main Methods:

• Literature review focusing on in vivo studies of alpha-tocopherol.
• Analysis of studies measuring inflammatory markers, cytokine release, and cell adhesion.

Main Results:

• Alpha-tocopherol therapy, particularly at high doses, reduces pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) and chemokine (IL-8) release.
• It decreases monocyte adhesion to endothelium and lowers C-reactive protein (CRP) levels in patients with CVD and risk factors.
• Supplementation with alpha-tocopherol has been shown to decrease pro-inflammatory cytokines and plasminogen activator inhibitor-1 (PAI-1) levels in vivo.

Conclusions:

• Alpha-tocopherol exhibits significant anti-inflammatory properties demonstrated in vivo.
• Its ability to modulate inflammatory pathways suggests a potential therapeutic role in cardiovascular disease management.